Skip to main content
Premium Trial:

Request an Annual Quote

Courtagen Inks NGS Test Distribution Agreement with Sciencewerke

NEW YORK (GenomeWeb) – Courtagen Life Sciences said today that it has partnered with Sciencewerke for the international distribution of its clinical next-generation sequencing tests.

Sciencewerke is a sales, marketing, and distribution company. It is headquartered in Singapore and has offices in Malaysia and Indonesia. It will distribute Courtagen's NGS-based tests for neurological and metabolic disorders.

The distribution agreement is "an important part of global strategy to support the increasing demand of our products," Brendan McKernan, president of Courtagen, said in a statement.

"We are excited to expand our molecular diagnostic offering to include Courtagen’s clinical testing for neurodevelopmental disorders, epilepsy, and mitochondrial disease," Vijay Bhandari, business development director at Sciencewerke, said in the statement. "We look forward to quickly making these tests available to our medical facilities and clinicians throughout Singapore, Indonesia, and Malaysia."